EyePoint Pharmaceuticals
EYPT
#6028
Rank
โ‚น101.45 B
Marketcap
โ‚น1,210
Share price
5.75%
Change (1 day)
127.65%
Change (1 year)

Earnings for EyePoint Pharmaceuticals (EYPT)

Earnings in 2025 (TTM): -โ‚น20.28 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are โ‚น31.37 Million. a decrease over its 2024 earnings that were of -โ‚น13.74 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for EyePoint Pharmaceuticals from 2003 to 2025

Annual earnings

Year Earnings Change
2025 -โ‚น22.43 Billion63.24%
2024 -โ‚น13.74 Billion104.29%
2023 -โ‚น6.73 Billion-29.88%
2022 -โ‚น9.6 Billion87.2%
2021 -โ‚น5.13 Billion38.58%
2020 -โ‚น3.7 Billion-24.56%
2019 -โ‚น4.91 Billion
2017 -โ‚น2.24 Billion22.59%
2016 -โ‚น1.83 Billion-8.02%
2015 -โ‚น1.99 Billion-296.09%
2014 โ‚น1.01 B-174.02%
2013 -โ‚น1.37 Billion37.42%
2012 -โ‚น1 Billion-56.29%
2011 -โ‚น2.28 Billion-1062.38%
2010 โ‚น0.23 B-250.43%
2009 -โ‚น0.16 Billion-89.5%
2008 -โ‚น1.5 Billion
2005 -โ‚น0.93 Billion56.99%
2004 -โ‚น0.59 Billion73.7%
2003 -โ‚น0.34 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-โ‚น0.21 Billion-99.07% Bahamas
NRC Health
NRC
โ‚น2.66 B-111.90%๐Ÿ‡บ๐Ÿ‡ธ USA